Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Leigh Zawel currently holds 69,785 shares of Cullinan Oncology, Inc. (CGEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leigh Zawel has been a net seller of CGEM stock. They have purchased $0 and sold $4.7M worth of shares.
Leigh Zawel's most recent insider trade was on Feb 11, 2022, when they sold 32,500 shares at $0.00 per share.
Leigh Zawel serves as Executive at Cullinan Oncology, Inc. (CGEM). They have executed 17 insider transactions totaling $4.7M over their tenure at the company.
Leigh Zawel holds the position of Executive at Cullinan Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Leigh Zawel has shown a selling trading pattern, with $0 in total purchases and $4.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Leigh Zawel was on Aug 23, 2021, when they sold $815.4K worth of CGEM shares. This transaction involved 28,118 shares at $29.00 per share.
Leigh Zawel currently owns 69,785 shares of Cullinan Oncology, Inc. (CGEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Leigh Zawel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Leigh Zawel has 17 Form 4 filings on record as an insider at Cullinan Oncology, Inc..
Set alerts for Leigh Zawel and 40,000+ other insiders.